PHOTOCURE logo PHOTOCURE

Selskapsinformasjon

Ticker: PHO
Børsverdi: 1 745 MNOK
Nordnet 2 442
Avanza 355
Kommende hendelserHendelser ℹ️
Rapport: 29.07.2026
18.05.2026 17:00

AUA 2026: new studies demonstrated Blue Light Cystoscopy benefits in high-risk NMIBC management and cost comparison study

Press Release - Oslo, Norway, May 18, 2026: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the presentation of two Photocure-supported abstracts at the American Urological Association Annual Congress (AUA) 2026. The first highlighted the benefits of Blue Light Cystoscopy (BLC[®]), n...

Les hele pressemeldingen

Antall Eiere